role adjuv therapi colorect cancer decad disappoint adjuv therapi trial resect colorect cancer result basi cautiou optim adjuv fluorouracil-contain regimen modest treatment benefit colon adenocarcinoma promis chemotherapi approach present appear fluorouracil-levamisol fluorouracil-leucovorin regimen optim schedul dose agent portal vein chemotherapi infus studi promis inconclus result date data larg group studi avail role modal rectal cancer adjuv radiotherapi modest consist abil local recurr surviv advantag optim dose sequenc radiotherapi cooper group studi optim use radiotherapi combin chemotherapi independ role chemotherapi rectal cancer unclear suggest evid adjuv chemotherapi effect rectal cancer primari proxim periton reflect larg number unresolv question follow interim treatment recommend patient duke rectal colon adenocarcinoma appropri adjuv clinic trial feasibl set protocol sound rational duke rectal cancer combin chemotherapi postop radiotherapi chemotherapi fluorouracil leucovorin proxim colon tumor pelvic periton reflect improv surviv patient duke diseas adjuv therapi group clinic studi patient duke tumor fluorouracil-levamisol 